Senseonics (United States).
company in Germantown, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 34
What's happening
Gone quiet
No new reports in 90+ days-
Senseonics reported 79% new patient growth while Abbott secured private placement funding, coinciding with CMS updating the Medicare Physician Fee Schedule.Some support1 report
-
Senseonics operates within the medical technology industry.Some support1 report
-
Ascensia Diabetes Care is a member of the PHC Group, and Senseonics appointed Brian Hansen as Chief Commercial Officer, leveraging his experience at Tandem.Some support1 report
-
Ascensia transfers Eversense distribution to Senseonics, accelerating growth and involving Brian Hansen's team transition.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Senseonics (United States)
Events traced to Senseonics (United States), step by step, newest firstAround Senseonics (United States) this week
News at the entities that move Senseonics (United States) most-
FDA StructuralFDA confirmed CMC and device plans are Phase 3 ready, coinciding with strengthening of US and EU patent estates.Moves Senseonics (United States)
-
Abbott Laboratories TransactionalMeta received a fine from New Mexico, while Musk considered a Tesla merger, and Abbott and Lodestone announced corporate changes.Moves Senseonics (United States)
-
RBC Capital Markets TransactionalRBC Capital Markets downgraded Lloyds Banking Group citing increased deposit competition.Moves Senseonics (United States)
-
TD Cowen TransactionalTD Cowen raised its price target for Celcuity Inc., which saw a stock price increase driven by a bullish rating.Moves Senseonics (United States)
Connections
The 7 strongest of 34, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Brian Hansen Structural
Brian Hansen joined Senseonics as Chief Commercial Officer, establishing an executive employment relationship.
-
Ascensia Diabetes Care (Switzerland) Transactional
Ascensia transferred the distribution rights of Eversense 365 to Senseonics.
-
Abbott Laboratories Transactional
Abbott Laboratories acquired shares in Senseonics through a private placement deal.
-
FDA Structural
FDA formally approved Senseonics' Eversense 365 system, establishing a critical regulatory dependency.
-
TD Cowen Transactional
TD Cowen served as a joint book-running manager for Senseonics' capital offering.
-
Senseonics filed public offerings and shelf registration statements with the Securities and Exchange Commission (Bangladesh) as part of regulatory compliance.
-
RBC Capital Markets Transactional
RBC Capital Markets served as the bookrunner for Senseonics' proposed securities offering.
History
Events by the month they beganJune 2026
4 events- Senseonics reported 79% new patient growth while Abbott secured private placement funding, coinciding with CMS updating the Medicare Physician Fee Schedule.
- Senseonics operates within the medical technology industry.
- Ascensia Diabetes Care is a member of the PHC Group, and Senseonics appointed Brian Hansen as Chief Commercial Officer, leveraging his experience at Tandem.
- Ascensia transfers Eversense distribution to Senseonics, accelerating growth and involving Brian Hansen's team transition.